APA (7th ed.) Citation

Eckes, J., Schmah, O., Siebers, J. W., Groh, U., Zschiedrich, S., Rautenberg, B., . . . Pütz, G. (2011). Kinetic Targeting of pegylated liposomal Doxorubicin: A new Approach to Reduce Toxicity during Chemotherapy (CARL-trial). BMC cancer, 11(1), 337. https://doi.org/10.1186/1471-2407-11-337

Chicago Style (17th ed.) Citation

Eckes, Jürgen, et al. "Kinetic Targeting of Pegylated Liposomal Doxorubicin: A New Approach to Reduce Toxicity During Chemotherapy (CARL-trial)." BMC Cancer 11, no. 1 (2011): 337. https://doi.org/10.1186/1471-2407-11-337.

MLA (9th ed.) Citation

Eckes, Jürgen, et al. "Kinetic Targeting of Pegylated Liposomal Doxorubicin: A New Approach to Reduce Toxicity During Chemotherapy (CARL-trial)." BMC Cancer, vol. 11, no. 1, 2011, p. 337, https://doi.org/10.1186/1471-2407-11-337.